Emerging data indicates that retatrutide, a innovative medication, may represent a significant advance in weight loss . This therapy combines the effects of a GLP-1 analog and a GIP analog, possibly offering a enhanced outcome than existing therapies . Patient research have demonstrated positive outcomes, including considerable reductions in weigh